Auxilium Pharmaceuticals Inc. (AUXL) saw a big move last session, as the company’s shares fell by nearly 6% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This continues the recent downtrend for AUXL, as the stock is now down over 8% since June 19.
This slump shouldn’t be too much of a surprise to investors, as the specialty biopharmaceutical company has seen 1 negative revision in the past few weeks and its current year loss consensus has widened over the last 30 days. This suggests there may be more trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent slump will continue, as the earnings picture definitely suggests that this might be the case.
AUXL currently has a Zacks Rank #5 (Strong Sell) while its Earnings ESP is negative.
Some better-ranked stocks in the Medical-Drugs industry include Aerie Pharmaceuticals, Inc. (AERI), Aeolus Pharmaceuticals Inc. (AOLS) and Ariad Pharmaceuticals Inc. (ARIA). All these stocks carry a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
AUXILIUM PHARMACEUTICALS INC (AUXL): Free Stock Analysis Report
AERIE PHARMACEUTICALS INC (AERI): Free Stock Analysis Report
AEOLUS PHARMACEUTICL (AOLS): Free Stock Analysis Report
ARIAD PHARMACEUTICALS INC (ARIA): Free Stock Analysis Report
Zacks Investment Research
- Health Care Industry
- Finance Trading